{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:52:26Z","timestamp":1781653946055,"version":"3.54.5"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202310159008"],"award-info":[{"award-number":["202310159008"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31471091"],"award-info":[{"award-number":["31471091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21677030"],"award-info":[{"award-number":["21677030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116764","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T03:47:09Z","timestamp":1716781629000},"page":"116764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Research progress on the protective effect of hormones and hormone drugs in myocardial ischemia-reperfusion injury"],"prefix":"10.1016","volume":"176","author":[{"given":"Zhongyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaojiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116764_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2024.116764_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/FJC.0000000000000640","article-title":"Panax notoginseng saponins attenuate myocardial ischemia-reperfusion injury through the HIF-1alpha\/BNIP3 pathway of autophagy","volume":"73","author":"Liu","year":"2019","journal-title":"J. Cardiovasc Pharm."},{"issue":"23","key":"10.1016\/j.biopha.2024.116764_bib3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","article-title":"Myocardial reperfusion injury: looking beyond primary PCI","volume":"34","author":"Fr\u00f6hlich","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2024.116764_bib4","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.112.115089","article-title":"Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models","volume":"126","author":"Ogura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116764_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3892\/etm.2022.11357","article-title":"Myocardial ischemia\/reperfusion injury: mechanisms of injury and implications for management (Review)","volume":"23","author":"He","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2024.116764_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/auto.18658","article-title":"Enhancing lysosome biogenesis attenuates BNIP3-induced cardiomyocyte death","volume":"8","author":"Ma","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2024.116764_bib7","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/475675","article-title":"Metabolic basis for thyroid hormone liver preconditioning: upregulation of AMP-activated protein kinase signaling","volume":"2012","author":"Videla","year":"2012","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"10.1016\/j.biopha.2024.116764_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038425","article-title":"Age and ovariectomy abolish beneficial effects of femalesex on rat ventricular myocytes exposed to simulated ischemia and reperfusion","volume":"7","author":"Ross","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2024.116764_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bph.12270","article-title":"Sex-based differences in cardiac ischaemic injury andprotection: therapeutic implications","volume":"171","author":"Ostadal","year":"2014","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib10","doi-asserted-by":"crossref","first-page":"5523516","DOI":"10.1155\/2021\/5523516","article-title":"Protective effects of estrogen on cardiovascular disease mediated by oxidative stress","volume":"2021","author":"Xiang","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116764_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1210\/er.2018-00087","article-title":"Estrogen receptors: new directions in the newmillennium","volume":"39","author":"Hewitt","year":"2018","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2024.116764_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/scipharm84030409","article-title":"Estrogen receptor ligands: a review (2013-2015)","volume":"84","author":"Farzaneh","year":"2016","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fendo.2019.00310","article-title":"The role of 17\u03b2-estradiol and estrogen receptorsin regulation of Ca2+ channels and mitochondrial function in cardiomyocytes","volume":"10","author":"Mahmoodzadeh","year":"2019","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.biopha.2024.116764_bib14","doi-asserted-by":"crossref","first-page":"H2204","DOI":"10.1152\/ajpheart.01219.2005","article-title":"Estrogen receptor-alphamediates acute myocardial protection in females","volume":"290","author":"Wang","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2024.116764_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.redox.2014.11.001","article-title":"Estradiol improvescardiovascular function through up-regulation of SOD2 on vascular wall","volume":"3","author":"Liu","year":"2014","journal-title":"Redox Biol."},{"issue":"18","key":"10.1016\/j.biopha.2024.116764_bib16","article-title":"Menopausal stage differences in endothelial resistance to ischemia-reperfusion injury","volume":"11","author":"Delgado Spicuzza","year":"2023","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.biopha.2024.116764_bib17","doi-asserted-by":"crossref","unstructured":"Millis R.M., Asadi M.S., Bond V. Jr, Haddad G.E.. Epigenetics, Protein Kinases and Heart Failure. Epigenetics and Epigenomics. InTech;2014. DOI:10.5772\/57194.","DOI":"10.5772\/57194"},{"issue":"2","key":"10.1016\/j.biopha.2024.116764_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10557-020-06949-3","article-title":"Oestrogen Receptor \u03b2 ActivationProtects Against Myocardial Infarction via Notch1 Signalling","volume":"34","author":"Du","year":"2020","journal-title":"Cardiovasc Drug."},{"issue":"12","key":"10.1016\/j.biopha.2024.116764_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293630","article-title":"GPER activation attenuates cardiac dysfunction by upregulating the SIRT1\/3-AMPK-UCP2 pathway in postmenopausal diabetic rats","volume":"18","author":"Azizian","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2012.03.007","article-title":"Estrogen and the cardiovascular system","volume":"135","author":"Knowlton","year":"2012","journal-title":"Pharm. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116764_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCULATIONAHA.109.868729","article-title":"Estrogen receptor-beta activationresults in S-nitrosylation of proteins involved in cardioprotection","volume":"120","author":"Lin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116764_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13293-016-0104-8","article-title":"Reduction of apoptosis and preservation of mitochondrial integrity under ischemia\/reperfusion injury is mediated by estrogen receptor \u03b2","volume":"7","author":"Schubert","year":"2016","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.biopha.2024.116764_bib23","article-title":"Role of estrogen receptors in health and disease","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12964-022-00842-2","article-title":"Estrogen inhibits endoplasmic reticulum stress and ameliorates myocardial ischemia\/reperfusion injury in rats by upregulating SERCA2a","volume":"20","author":"Chen","year":"2022","journal-title":"Cell Commun. Signal"},{"issue":"5","key":"10.1016\/j.biopha.2024.116764_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jmedgenet-2017-105120","article-title":"New insights into SERCA2a gene therapy in heartfailure: pay attention to the negative effects of B-type natriuretic peptides","volume":"55","author":"Zhai","year":"2018","journal-title":"JMed Genet"},{"key":"10.1016\/j.biopha.2024.116764_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yjmcc.2019.07.009","article-title":"Roles and mechanisms of SUMOylation onkey proteins in myocardial ischemia\/reperfusion injury","volume":"134","author":"Chen","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116764_bib27","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.3390\/ijms21093244","article-title":"The Impact of Estrogen Receptor in Arterial and Lymphatic Vascular Diseases","volume":"21","author":"Fontaine","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116764_bib28","first-page":"193","article-title":"G-protein coupled estrogen receptor 1 expression in rat and humanheart: Protective role during ischaemic stress","volume":"26","author":"Patel","year":"2010","journal-title":"Int J. Mol. Med"},{"issue":"9","key":"10.1016\/j.biopha.2024.116764_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135988","article-title":"G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection viaMEK\/ERK\/GSK-3\u03b2 Pathway after Ischemia\/Reperfusion","volume":"10","author":"Kabir","year":"2015","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.biopha.2024.116764_bib30","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1111\/bph.14033","article-title":"Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardiumagainst ischemia\/reperfusion injury by reducing mitochondrial dysfunction andmitophagy","volume":"174","author":"Feng","year":"2017","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114599","article-title":"Mechanistic correlation betweenmitochondrial permeability transition pores and mitochondrial ATP dependentpotassium channels in ischemia reperfusion","volume":"162","author":"Behera","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.116764_bib32","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2174\/1874467214666210120145537","article-title":"Exploring theMitochondrial Apoptotic Cell Death Landscape and Associated Components Servingas Molecular Targets, Primarily for Synthetic and Natural Drugs TargetingOncology Therapeutics","volume":"14","author":"Kaur","year":"2021","journal-title":"Curr. Mol. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2024.116764_bib33","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.116.303790","article-title":"Molecular mechanisms of mitochondrialautophagy\/mitophagy in the heart","volume":"116","author":"Saito","year":"2015","journal-title":"Circ. Res"},{"issue":"23","key":"10.1016\/j.biopha.2024.116764_bib34","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1111\/bph.14033","article-title":"Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia\/reperfusion injury by reducing mitochondrial dysfunction and mitophagy","volume":"174","author":"Feng","year":"2017","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib35","doi-asserted-by":"crossref","first-page":"H16","DOI":"10.1152\/ajpheart.00588.2009","article-title":"A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury","volume":"298","author":"Bopassa","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116764_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/pr.114.009712","article-title":"International Union of Basic and ClinicalPharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its PharmacologicModulators","volume":"67","author":"Prossnitz","year":"2015","journal-title":"Pharm. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/gme.0b013e3181b4c4ac","article-title":"Cardioprotective effects of long-term treatment with raloxifene, a selectiveestrogen receptor modulator, on myocardial ischemia\/reperfusion injury inovariectomized rats","volume":"17","author":"Chung","year":"2010","journal-title":"Menopause"},{"issue":"Pt 2","key":"10.1016\/j.biopha.2024.116764_bib38","first-page":"515","article-title":"Risks and benefits of hormone replacement therapy for the prevention of cardiovascular disease","volume":"44 Suppl 1","author":"Sarrel","year":"1999","journal-title":"Cardiologia"},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1152\/physiolgenomics.00029.2015","article-title":"Pharmacogenomics of estrogens on changes in carotid artery intima-medialthickness and coronary arterial calcification: Kronos Early Estrogen PreventionStudy","volume":"48","author":"Miller","year":"2016","journal-title":"Physiol. Genom."},{"issue":"13","key":"10.1016\/j.biopha.2024.116764_bib41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"ELITE Research Group.Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N. Engl J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heartjnl-2015-308287","article-title":"Cochrane corner: oralhormone therapy and cardiovascular outcomes in post-menopausal women","volume":"102","author":"Boardman","year":"2016","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.biopha.2024.116764_bib43","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/AOG.0000000000000461","article-title":"Coronary heart disease mortality and hormone therapybefore and after the Women's Health Initiative","volume":"124","author":"Tuomikoski","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116764_bib44","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2015-1864","article-title":"Increased Cardiovascular Mortality Risk in WomenDiscontinuing Postmenopausal Hormone Therapy","volume":"100","author":"Mikkola","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2024.116764_bib45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jamainternmed.2016.2761","article-title":"Guideline Development Group for Menopause:Diagnosis and Management (NICE Clinical Guideline No. 23). Diagnosis andManagement of Menopause: The National Institute of Health and Care Excellence(NICE) Guideline","volume":"176","author":"Lumsden","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.biopha.2024.116764_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/VHRM.S173259","article-title":"Role ofandrogens in cardiovascular pathology","volume":"14","author":"Chistiakov","year":"2018","journal-title":"Vasc. Health Risk Manag"},{"issue":"2","key":"10.1016\/j.biopha.2024.116764_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.eururo.2008.12.037","article-title":"Androgens andmorphologic remodeling at penile and cardiovascular levels: a common piece incomplicated puzzles?","volume":"56","author":"Mirone","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2024.116764_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13293-015-0027-9","article-title":"Testosterone modulates cardiac contraction and calciumhomeostasis: cellular and molecular mechanisms","volume":"6","author":"Ayaz","year":"2015","journal-title":"Biol. Sex. Differ."},{"issue":"4","key":"10.1016\/j.biopha.2024.116764_bib49","article-title":"Testosterone and the cardiovascularsystem: a comprehensive review of the basic science literature","volume":"2","author":"Herring","year":"2013","journal-title":"J. Am. Heart"},{"key":"10.1016\/j.biopha.2024.116764_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.712237","article-title":"Low serum testosterone concentrations are associated with poor cognitive performance in older men but not women","volume":"13","author":"Dong","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"23","key":"10.1016\/j.biopha.2024.116764_bib51","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","article-title":"Endogenous testosterone and mortality due to all causes, cardiovascular disease,and cancer in men: European prospective investigation into cancer in Norfolk(EPIC-Norfolk) Prospective Population Study","volume":"116","author":"Khaw","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2024.116764_bib52","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2015.12.005","article-title":"Mohler ER 3rd. Testosterone andCardiovascular Disease","volume":"67","author":"Kloner","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116764_bib53","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/en.2013-1755","article-title":"MihailidouAS. Role of androgens in sex differences in cardiac damage during myocardialinfarction","volume":"155","author":"Le","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2024.116764_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2017.06.011","article-title":"Testosterone deficiency prevents left ventricular contractility dysfunction after myocardial infarction","volume":"460","author":"Ribeiro J\u00fanior","year":"2018","journal-title":"Mol. Cell Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13293-019-0256-4","article-title":"Ischemia and reperfusion injury followingcardioplegic arrest is attenuated by age and testosterone deficiency in male butnot female mice","volume":"10","author":"Ghimire","year":"2019","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.biopha.2024.116764_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yjmcc.2018.08.011","article-title":"Anti-androgenic therapy with finasteride improves cardiac function, attenuatesremodeling and reverts pathologic gene-expression after myocardial infarction inmice","volume":"122","author":"Froese","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116764_bib57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.surg.2009.03.035","article-title":"Bothendogenous and exogenous testosterone decrease myocardial STAT3 activation andSOCS3 expression after acute ischemia and reperfusion","volume":"146","author":"Wang","year":"2009","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib58","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jss.2010.07.041","article-title":"Testosterone-down-regulated Aktpathway during cardiac ischemia\/reperfusion: a mechanism involving BAD, Bcl-2and FOXO3a","volume":"164","author":"Huang","year":"2010","journal-title":"J. Surg. Res"},{"key":"10.1016\/j.biopha.2024.116764_bib59","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3389\/fimmu.2020.01647","article-title":"Supraphysiological Levels of Testosterone Induce Vascular Dysfunction via Activation of the NLRP3 Inflammasome","volume":"11","author":"Alves","year":"2020","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116764_bib60","doi-asserted-by":"crossref","first-page":"R1168","DOI":"10.1152\/ajpregu.00833.2005","article-title":"Brief exposure toexogenous testosterone increases death signaling and adversely affectsmyocardial function after ischemia","volume":"290","author":"Crisostomo","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116764_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122503","article-title":"Chronic testosterone replacementexerts cardioprotection against cardiac ischemia-reperfusion injury byattenuating mitochondrial dysfunction in testosterone-deprived rats","volume":"10","author":"Pongkan","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2024.116764_bib62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjp.0707624","article-title":"Testosterone protects rat hearts againstischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation","volume":"153","author":"Tsang","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"1-3","key":"10.1016\/j.biopha.2024.116764_bib63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2012.03.032","article-title":"Testosterone replacementtherapy promotes angiogenesis after acute myocardial infarction by enhancingexpression of cytokines HIF-1a, SDF-1a and VEGF","volume":"684","author":"Chen","year":"2012","journal-title":"Eur. J. Pharm."},{"issue":"16","key":"10.1016\/j.biopha.2024.116764_bib64","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/cells12162077","article-title":"Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives","volume":"12","author":"Medzikovic","year":"2023","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.biopha.2024.116764_bib65","doi-asserted-by":"crossref","first-page":"BR266","DOI":"10.12659\/MSM.881930","article-title":"Testosterone-induced hypertrophy, fibrosis and apoptosis ofcardiac cells--an ultrastructural and immunohistochemical study","volume":"17","author":"Papamitsou","year":"2011","journal-title":"Med Sci. Monit."},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1074248415587977","article-title":"Roles of Testosterone Replacementin Cardiac Ischemia-Reperfusion Injury","volume":"21","author":"Pongkan","year":"2016","journal-title":"J. Cardiovasc Pharm. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116764_bib67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.steroids.2012.12.004","article-title":"Testosterone metabolites mediate its effects on myocardial damage induced byischemia\/reperfusion in male Wistar rats","volume":"78","author":"Rubio-Gayosso","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.biopha.2024.116764_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110423","article-title":"Testosterone therapy in hypogonadal patientsand the associated risks of cardiovascular events","volume":"129","author":"Kharaba","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085805","article-title":"FraumeniJF Jr, Hoover RN. Increased risk of non-fatal myocardial infarction followingtestosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2024.116764_bib70","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With LowTestosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.biopha.2024.116764_bib71","article-title":"Testosterone replacement therapy in hypogonadal men and myocardial infarction risk: systematic review & meta-analysis","volume":"13","author":"Lee","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.biopha.2024.116764_bib72","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in mentreated with testosterone replacement therapy: an intention-to-treatobservational cohort study","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116764_bib73","first-page":"759","article-title":"Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke","volume":"194","author":"Seftel","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.biopha.2024.116764_bib74","doi-asserted-by":"crossref","unstructured":"Lincoff A.M., Bhasin S., Flevaris P., Mitchell L.M., Basaria S., Boden W.E.,Cunningham G.R., Granger C.B., Khera M., Thompson I.M. Jr, Wang Q., Wolski K., Davey D.,Kalahasti V., Khan N., Miller M.G., Snabes M.C., Chan A., Dubcenco E., Li X., Yi T., HuangB, Pencina K.M., Travison T.G., Nissen S.E.; TRAVERSE Study Investigators.Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023Jul 13;389(2):107-117. DOI: 10.1056\/NEJMoa2215025.","DOI":"10.1056\/NEJMoa2215025"},{"key":"10.1016\/j.biopha.2024.116764_bib75","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/475675","article-title":"Metabolic basis for thyroid hormone liver preconditioning: upregulation of AMP-activated protein kinase signaling","volume":"2012","author":"Videla","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.biopha.2024.116764_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109220","article-title":"Thyroid hormone postconditioning protects hearts from ischemia\/reperfusion through reinforcing mitophagy","volume":"118","author":"Bi","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib77","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1210\/en.2014-1106","article-title":"Triiodothyronine prevents cardiac ischemia\/reperfusion mitochondrial impairment and cell loss by regulating miR30a\/p53 axis","volume":"155","author":"Forini","year":"2014","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib78","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40635-021-00382-y","article-title":"Triiodothyronine prevents tissue hypoxia in experimental sepsis: potential therapeutic implications","volume":"9","author":"Mourouzis","year":"2021","journal-title":"Intensive Care Med Exp."},{"key":"10.1016\/j.biopha.2024.116764_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/481482","article-title":"The emerging role of TRalpha1 in cardiac repair: potential therapeutic implications","volume":"2014","author":"Pantos","year":"2014","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2024.116764_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yexcr.2019.05.003","article-title":"Thyroid hormone protects cardiomyocytes from H(2)O(2)-induced oxidative stress via the PI3K-AKT signaling pathway.","volume":"380","author":"Zeng","year":"2019","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.biopha.2024.116764_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00395-021-00868-6","article-title":"Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes","volume":"116","author":"Lieder","year":"2021","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.biopha.2024.116764_bib82","article-title":"Thyroid Hormone Metabolite 3-Iodothyronamine (T1AM) Alleviates Hypoxia\/Reoxygenation-Induced Cardiac Myocyte Apoptosis via Akt\/FoxO1 Pathway","volume":"26","author":"Zhou","year":"2020","journal-title":"Med Sci. Monit."},{"key":"10.1016\/j.biopha.2024.116764_bib83","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/pr.112.007203","article-title":"Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance","volume":"66","author":"O'Connell","year":"2014","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2024.116764_bib84","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/10799893.2020.1799291","article-title":"alpha(1)-Adrenergic receptors increase glucose oxidation under normal and ischemic conditions in adult mouse cardiomyocytes","volume":"41","author":"Papay","year":"2021","journal-title":"J. Recept Signal Transduct. Res"},{"key":"10.1016\/j.biopha.2024.116764_bib85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/10799893.2015.1091475","article-title":"alpha1A-Adrenergic receptor prevents cardiac ischemic damage through PKCdelta\/GLUT1\/4-mediated glucose uptake","volume":"36","author":"Shi","year":"2016","journal-title":"J. Recept Signal Transduct. Res"},{"key":"10.1016\/j.biopha.2024.116764_bib86","doi-asserted-by":"crossref","first-page":"E577","DOI":"10.1152\/ajpendo.00014.2017","article-title":"Glucose oxidation positively regulates glucose uptake and improves cardiac function recovery after myocardial reperfusion","volume":"313","author":"Li","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2024.116764_bib87","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/10799893.2016.1193522","article-title":"The role of alpha(1)-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation","volume":"37","author":"Shi","year":"2017","journal-title":"J. Recept Signal Transduct. Res"},{"key":"10.1016\/j.biopha.2024.116764_bib88","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbadis.2011.12.013","article-title":"Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia\/reperfusion injury in rat heart","volume":"1822","author":"Ibacache","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2024.116764_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110188","article-title":"Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia\/reperfusion injury in diabetic rats by activating PI3K\/Akt signaling in vivo and in vitro","volume":"127","author":"Chang","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib90","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jcmm.14795","article-title":"Dexmedetomidine post-treatment attenuates cardiac ischaemia\/reperfusion injury by inhibiting apoptosis through HIF-1alpha signalling","volume":"24","author":"Peng","year":"2020","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.116764_bib91","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1213\/ANE.0000000000004417","article-title":"Characteristics of Dexmedetomidine Postconditioning in the Field of Myocardial Ischemia-Reperfusion Injury","volume":"130","author":"Bunte","year":"2020","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.biopha.2024.116764_bib92","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3071959","article-title":"Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia\/Reperfusion Injury in Diabetic Rats: Role of the PI3K\/Akt-Dependent Signaling Pathway","volume":"2018","author":"Cheng","year":"2018","journal-title":"J. Diabetes Res"},{"key":"10.1016\/j.biopha.2024.116764_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051445","article-title":"Influence of Hyperglycemia on Dexmedetomidine-Induced Cardioprotection in the Isolated Perfused Rat Heart","volume":"9","author":"Torregroza","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2024.116764_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108837","article-title":"Dexmedetomidine preconditioning attenuates ischemia\/reperfusion injury in isolated rat hearts with endothelial dysfunction","volume":"114","author":"He","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib95","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1177\/0300060519856750","article-title":"Pre-cardiopulmonary bypass administration of dexmedetomidine decreases cardiac troponin I level following cardiac surgery with sevoflurane postconditioning","volume":"47","author":"Zhou","year":"2019","journal-title":"J. Int Med Res"},{"key":"10.1016\/j.biopha.2024.116764_bib96","first-page":"7409","article-title":"The effect of dexmedetomidine on myocardial ischemia\/reperfusion injury in patients undergoing cardiac surgery with cardiopulmonary bypass: a meta-analysis","volume":"25","author":"Zhang","year":"2021","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbi.2015.08.012","article-title":"Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease","volume":"50","author":"Hong","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2024.116764_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109039","article-title":"Detailed insight on \u03b2-adrenoceptors astherapeutic targets","volume":"117","author":"Velmurugan","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib99","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.smim.2014.01.003","article-title":"Neuroendocrine regulation of inflammation","volume":"26","author":"Padro","year":"2014","journal-title":"Semin Immunol."},{"key":"10.1016\/j.biopha.2024.116764_bib100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.phrs.2015.07.001","article-title":"Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions","volume":"101","author":"Diaz-Araya","year":"2015","journal-title":"Pharm. Res"},{"issue":"2","key":"10.1016\/j.biopha.2024.116764_bib101","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202313436","article-title":"Persistent PKA activation redistributes NaV1.5 to the cell surface of adult rat ventricular myocytes","volume":"156","author":"Bernas","year":"2024","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.biopha.2024.116764_bib102","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00424-014-1515-1","article-title":"Cyclic AMP synthesis and hydrolysis in the normal and failing heart","volume":"466","author":"Guellich","year":"2014","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.biopha.2024.116764_bib103","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ejhf.714","article-title":"The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial","volume":"19","author":"Bundgaard","year":"2017","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2024.116764_bib104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10557-010-6275-3","article-title":"The role of beta-adrenergic receptors in the cardioprotective effects of beta-preconditioning (betaPC)","volume":"25","author":"Salie","year":"2011","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.biopha.2024.116764_bib105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bcp.2011.06.041","article-title":"beta(1)-adrenergic receptor-mediated HO-1 induction, via PI3K and p38 MAPK, by isoproterenol in RAW 264.7 cells leads to inhibition of HMGB1 release in LPS-activated RAW 264.7 cells and increases in survival rate of CLP-induced septic mice","volume":"82","author":"Ha","year":"2011","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib106","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijcard.2012.09.225","article-title":"Heme oxygenase-1: an important therapeutic target for protecting against myocardial ischemia and reperfusion injury","volume":"167","author":"Hu","year":"2013","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.biopha.2024.116764_bib107","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1161\/CIRCULATIONAHA.108.769331","article-title":"High-mobility group box-1 in ischemia-reperfusion injury of the heart","volume":"117","author":"Andrassy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116764_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115118","article-title":"HMGB family proteins: potential biomarkers and mechanistic factors in cardiovascular diseases","volume":"165","author":"Zheng","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.116764_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228507","article-title":"beta2-Adrenergic Receptors Increase Cardiac Fibroblast Proliferation Through the Galphas\/ERK1\/2-Dependent Secretion of Interleukin-6","volume":"21","author":"Tanner","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.116764_bib111","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1476-5381.2010.00813.x","article-title":"Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia\/reperfusion in anaesthetized rats","volume":"160","author":"Zhang","year":"2010","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00395-019-0741-2","article-title":"Inducible cardiac-specific overexpression of cyclooxygenase-2 (COX-2) confers resistance to ischemia\/reperfusion injury","volume":"114","author":"Guo","year":"2019","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.biopha.2024.116764_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114858","article-title":"Prostaglandin E2 EP receptors in cardiovasculardisease: An update","volume":"195","author":"Bryson","year":"2022","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib114","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1324347","article-title":"Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia\/Reperfusion Injury and Cardiac Hypertrophy","volume":"2016","author":"Pang","year":"2016","journal-title":"J. Diabetes Res"},{"key":"10.1016\/j.biopha.2024.116764_bib115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cvr\/cvn254","article-title":"Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia\/reperfusion injury","volume":"81","author":"Hishikari","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2024.116764_bib116","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.5966\/sctm.2015-0020","article-title":"Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.biopha.2024.116764_bib117","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/pr.110.003517","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress","volume":"63","author":"Woodward","year":"2011","journal-title":"Pharm. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2024.116764_bib118","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.3390\/ijms24044193","article-title":"The Link between Prostanoids and Cardiovascular Diseases","volume":"24","author":"Beccacece","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121277","article-title":"Deleterious effects of cardiomyocyte-specific prostaglandin E2 EP3 receptor overexpression on cardiac function after myocardial infarction","volume":"313","author":"Maxwell","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/cvr\/cvn312","article-title":"Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart","volume":"81","author":"Meyer-Kirchrath","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2024.116764_bib121","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plefa.2011.01.003","article-title":"Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor","volume":"84","author":"Harding","year":"2011","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"key":"10.1016\/j.biopha.2024.116764_bib122","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009216","article-title":"Hsieh P. Prostaglandin E(2) Receptor 2 Modulates Macrophage Activity for Cardiac Repair","volume":"7","author":"Wu","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2024.116764_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239020","article-title":"Effect of Prostanoids on Human Platelet Function: An Overview","volume":"21","author":"Braune","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib124","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41419-021-04402-3","article-title":"Misoprostol treatment prevents hypoxia-induced cardiac dysfunction through a 14-3-3 and PKA regulatory motif on Bnip3","volume":"12","author":"Martens","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116764_bib125","first-page":"1030","article-title":"Effects of pretreatment with prostaglandin E1 on potassium channels in ischemia\/reperfusion guinea pigs ventricular myocytes","volume":"29","author":"Jiao","year":"2013","journal-title":"Chin. Pharmacol. Bull."},{"key":"10.1016\/j.biopha.2024.116764_bib126","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1631\/jzus.B1101007","article-title":"Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow","volume":"12","author":"Li","year":"2011","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.biopha.2024.116764_bib127","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.4103\/0366-6999.156078","article-title":"Effect of Intravenous Administration of Liposomal Prostaglandin E1 on Microcirculation in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention","volume":"128","author":"Wei","year":"2015","journal-title":"Chin. Med J. (Engl.)"},{"key":"10.1016\/j.biopha.2024.116764_bib128","article-title":"Effects of prostaglandin E1 on reperfusion injury patients: A meta-analysis of randomized controlled trials","volume":"96","author":"Zhu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.biopha.2024.116764_bib129","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00380-022-02219-4","article-title":"Prostaglandin E2 mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP4","volume":"38","author":"Kanno","year":"2023","journal-title":"Heart Vessels"},{"key":"10.1016\/j.biopha.2024.116764_bib130","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI59262","article-title":"Niacin and biosynthesis of PGD(2)by platelet COX-1 in mice and humans","volume":"122","author":"Song","year":"2012","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2024.116764_bib131","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s12630-019-01309-8","article-title":"Effect of iloprost inhalation on postoperative outcome in high-risk cardiac surgical patients: a prospective randomized-controlled multicentre trial (ILOCARD)","volume":"66","author":"Winterhalter","year":"2019","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.biopha.2024.116764_bib132","first-page":"325","article-title":"Melatonin: exceeding expectations","volume":"29","author":"Reiter","year":"2014","journal-title":"Physiology\u00a0(Bethesda)"},{"key":"10.1016\/j.biopha.2024.116764_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103480","article-title":"Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin","volume":"13","author":"Vasey","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.116764_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115475","article-title":"Melatonin as atherapeutic agent for alleviating endothelial dysfunction in cardiovasculardiseases: Emphasis on oxidative stress","volume":"167","author":"Zhang","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib135","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1111\/jcmm.16691","article-title":"Cardioprotective effects of melatonin against myocardial ischaemia\/reperfusion injury: Activation of AMPK\/Nrf2 pathway","volume":"25","author":"Xu","year":"2021","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.116764_bib136","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/jpi.12161","article-title":"Melatonin receptor-mediated protection against myocardial ischemia\/reperfusion injury: role of SIRT1","volume":"57","author":"Yu","year":"2014","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116764_bib137","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lfs.2019.04.057","article-title":"Melatonin protects circulatory death heart from ischemia\/reperfusion injury via the JAK2\/STAT3 signalling pathway","volume":"228","author":"Lan","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173295","article-title":"Angiotensin receptor-neprilysin inhibitior (thiorphan\/irbesartan) decreased ischemia-reperfusion induced ventricular arrhythmias in rat; in vivo study","volume":"882","author":"Abdulsalam","year":"2020","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246331","article-title":"Association Between Antiarrhythmic, Electrophysiological, and Antioxidative Effects of Melatonin in Ischemia\/Reperfusion","volume":"20","author":"Sedova","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511931","article-title":"Blockade of Melatonin Receptors Abolishes Its Antiarrhythmic Effect and Slows Ventricular Conduction in Rat Hearts","volume":"24","author":"Durkina","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib141","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.taap.2015.02.023","article-title":"Inhibition of NF-kappaB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress","volume":"284","author":"Yu","year":"2015","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib142","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0000000000000711","article-title":"Infusion of Melatonin Into the Paraventricular Nucleus Ameliorates Myocardial Ischemia-Reperfusion Injury by Regulating Oxidative Stress and Inflammatory Cytokines","volume":"74","author":"Yang","year":"2019","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib143","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/FJC.0000000000000851","article-title":"Activation of Paraventricular Melatonin Receptor 2 Mediates Melatonin-Conferred Cardioprotection Against Myocardial Ischemia\/Reperfusion Injury","volume":"76","author":"Zhang","year":"2020","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib144","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tox.2017.07.019","article-title":"Mitochondrial fusion, fission, and mitochondrial toxicity","volume":"391","author":"Meyer","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2024.116764_bib145","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41569-022-00703-y","article-title":"The role of mitochondrial fission in cardiovascular health and disease","volume":"19","author":"Quiles","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2024.116764_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02659","article-title":"Melatonin has profound effects on mitochondrial dynamics in myocardial ischaemia\/reperfusion","volume":"5","author":"Dube","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2024.116764_bib147","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12413","article-title":"Melatonin protects cardiac microvasculature against ischemia\/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis","volume":"63","author":"Zhou","year":"2017","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116764_bib148","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12542","article-title":"Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion\/mitophagy and activating the AMPK-OPA1 signaling pathways","volume":"66","author":"Zhang","year":"2019","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116764_bib149","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/FJC.0000000000000626","article-title":"Melatonin Attenuates Cardiac Reperfusion Stress by Improving OPA1-Related Mitochondrial Fusion in a Yap-Hippo Pathway-Dependent Manner","volume":"73","author":"Ma","year":"2019","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174157","article-title":"Melatonin postconditioning ameliorates anoxia\/reoxygenation injury by regulating mitophagy and mitochondrial dynamics in a SIRT3-dependent manner","volume":"904","author":"Bai","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib151","first-page":"2047","article-title":"Melatonin Attenuates Anoxia\/Reoxygenation Injury by Inhibiting Excessive Mitophagy Through the MT2\/SIRT3\/FoxO3a Signaling Pathway in H9c2 Cells","volume":"14","author":"Wu","year":"2020","journal-title":"Drug Des. Dev\u00a0Ther."},{"key":"10.1016\/j.biopha.2024.116764_bib152","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.18632\/aging.103078","article-title":"Melatonin improves mitochondrial biogenesis through the AMPK\/PGC1alpha pathway to attenuate ischemia\/reperfusion-induced myocardial damage","volume":"12","author":"Qi","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2024.116764_bib153","article-title":"Melatonin ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1alpha-SIRT3 signaling","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116764_bib154","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cbin.11759","article-title":"Temporal effect of melatonin posttreatment on anoxia\/reoxygenation injury in H9c2 cells","volume":"46","author":"Bai","year":"2022","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.biopha.2024.116764_bib155","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1007\/s11033-021-06351-8","article-title":"Nicotinamide mononucleotide and melatonin counteract myocardial ischemia-reperfusion injury by activating SIRT3\/FOXO1 and reducing apoptosis in aged male rats","volume":"48","author":"Jafari-Azad","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2024.116764_bib156","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00210-023-02383-y","article-title":"The additive effects of nicotinamide mononucleotide and melatonin on mitochondrial biogenesis and fission\/fusion, autophagy, and microRNA-499 in the aged rat heart with reperfusion injury","volume":"396","author":"Mokhtari","year":"2023","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib157","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1074248419882002","article-title":"Melatonin and Nicotinamide Mononucleotide Attenuate Myocardial Ischemia\/Reperfusion Injury via Modulation of Mitochondrial Function and Hemodynamic Parameters in Aged Rats","volume":"25","author":"Hosseini","year":"2020","journal-title":"J. Cardiovasc Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.116764_bib158","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.intimp.2018.12.028","article-title":"Role of pyroptosis in cardiovascular diseases","volume":"67","author":"Jia","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116764_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.733183","article-title":"Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis","volume":"9","author":"Lu","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2024.116764_bib160","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12698","article-title":"Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: Role of SIRT6","volume":"70","author":"Yu","year":"2021","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116764_bib161","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbadis.2017.11.023","article-title":"Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation","volume":"1864","author":"Yu","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116764_bib162","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12571","article-title":"Activation of melatonin receptor 2 but not melatonin receptor 1 mediates melatonin-conferred cardioprotection against myocardial ischemia\/reperfusion injury","volume":"67","author":"Han","year":"2019","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116764_bib163","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jare.2020.09.007","article-title":"Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection","volume":"29","author":"Singhanat","year":"2021","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.biopha.2024.116764_bib164","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuint.2016.12.011","article-title":"Neuroprotection of agomelatine against cerebral ischemia\/reperfusion injury through an antiapoptotic pathway in rat","volume":"102","author":"Chumboatong","year":"2017","journal-title":"Neurochem Int"},{"key":"10.1016\/j.biopha.2024.116764_bib165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/FJC.0000000000000600","article-title":"Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels","volume":"72","author":"Stroethoff","year":"2018","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib166","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10557-020-06972-4","article-title":"The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species","volume":"34","author":"Stroethoff","year":"2020","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.biopha.2024.116764_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072585","article-title":"Activation of PKG and Akt Is Required for Cardioprotection by Ramelteon-Induced Preconditioning and Is Located Upstream of mKCa-Channels","volume":"21","author":"Torregroza","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib168","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1213\/ANE.0000000000002625","article-title":"Activation of Melatonin Receptors by Ramelteon Induces Cardioprotection by Postconditioning in the Rat Heart","volume":"126","author":"Stroethoff","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.biopha.2024.116764_bib169","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/db16-0152","article-title":"Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture","volume":"65","author":"King","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2024.116764_bib170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10557-014-6553-6","article-title":"Roles of obese-insulin resistance and anti-diabetic drugs on the heart with ischemia-reperfusion injury","volume":"28","author":"Apaijai","year":"2014","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.biopha.2024.116764_bib171","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40256-014-0089-9","article-title":"The cardioprotection of the insulin-mediated PI3K\/Akt\/mTOR signaling pathway","volume":"14","author":"Yao","year":"2014","journal-title":"Am. J. Cardiovasc Drugs"},{"key":"10.1016\/j.biopha.2024.116764_bib172","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00395-013-0341-5","article-title":"NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury","volume":"108","author":"Sun","year":"2013","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.biopha.2024.116764_bib173","doi-asserted-by":"crossref","first-page":"873","DOI":"10.18632\/aging.100933","article-title":"Mutual inhibition of insulin signaling and PHLPP-1 determines cardioprotective efficiency of Akt in aged heart","volume":"8","author":"Xing","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2024.116764_bib174","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2010.08.017","article-title":"Survivin: a novel player in insulin cardioprotection against myocardial ischemia\/reperfusion injury","volume":"50","author":"Si","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2024.116764_bib175","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2147\/IJN.S160848","article-title":"Endogenous ornithine decarboxylase\/polyamine system mediated the antagonist role of insulin\/PEG-CMCS preconditioning against heart ischemia\/reperfusion injury in diabetes mellitus","volume":"13","author":"Tong","year":"2018","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2024.116764_bib176","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/536510","article-title":"Insulin preconditioning elevates p-Akt and cardiac contractility after reperfusion in the isolated ischemic rat heart","volume":"2014","author":"Sato","year":"2014","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.biopha.2024.116764_bib177","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2015.09.171","article-title":"Insulin\/NFkappaB protects against ischemia-induced necrotic cardiomyocyte death.","volume":"467","author":"Diaz","year":"2015","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2024.116764_bib178","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/14017431.2015.1071494","article-title":"Intermittent insulin treatment mimics ischemic postconditioning via MitoKATP channels, ROS, and RISK","volume":"49","author":"Helgeland","year":"2015","journal-title":"Scand. Cardiovasc J."},{"key":"10.1016\/j.biopha.2024.116764_bib179","doi-asserted-by":"crossref","first-page":"E871","DOI":"10.1152\/ajpendo.00623.2009","article-title":"Insulin attenuates myocardial ischemia\/reperfusion injury via reducing oxidative\/nitrative stress","volume":"298","author":"Ji","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2024.116764_bib180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2015.10.046","article-title":"Cardio-protective effects of combined l-arginine and insulin: Mechanism and therapeutic actions in myocardial ischemia-reperfusion injury","volume":"769","author":"Venardos","year":"2015","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116764_bib181","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10557-017-6731-4","article-title":"The Role of MKP-1 in Insulin-Induced Cardioprotection","volume":"31","author":"Webster","year":"2017","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.biopha.2024.116764_bib182","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/02676591221099807","article-title":"Insulin reduces pyroptosis-induced inflammation by PDHA1 dephosphorylation-mediated NLRP3 activation during myocardial ischemia-reperfusion injury","volume":"38","author":"Pan","year":"2023","journal-title":"Perfusion"},{"key":"10.1016\/j.biopha.2024.116764_bib183","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3892\/etm.2015.2534","article-title":"Erythropoietin pretreatment suppresses inflammation by activating the PI3K\/Akt signaling pathway in myocardial ischemia-reperfusion injury","volume":"10","author":"Rong","year":"2015","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.biopha.2024.116764_bib184","first-page":"690","article-title":"Innovative therapeutic strategies for cardiovascular disease","volume":"22","author":"Maiese","year":"2023","journal-title":"EXCLI J."},{"key":"10.1016\/j.biopha.2024.116764_bib185","doi-asserted-by":"crossref","first-page":"H2035","DOI":"10.1152\/ajpheart.00472.2009","article-title":"Myocardial reperfusion injury management: erythropoietin compared with postconditioning","volume":"297","author":"Tamareille","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2024.116764_bib186","doi-asserted-by":"crossref","first-page":"S467","DOI":"10.1097\/CCM.0b013e31818a8cec","article-title":"Cardioprotective effects of erythropoietin on postresuscitation myocardial dysfunction in appropriate therapeutic windows","volume":"36","author":"Huang","year":"2008","journal-title":"Crit. Care Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.116764_bib187","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1620\/tjem.227.83","article-title":"Current perspectives on protective roles of erythropoietin in cardiovascular system: erythropoietin receptor as a novel therapeutic target","volume":"227","author":"Kagaya","year":"2012","journal-title":"Tohoku J. Exp. Med"},{"key":"10.1016\/j.biopha.2024.116764_bib188","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejcts.2008.12.049","article-title":"Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production. E","volume":"35","author":"Mihov","year":"2009","journal-title":"Ur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.biopha.2024.116764_bib189","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1008-1275(08)60071-1","article-title":"Anti-inflammatory effect of erythropoietin pretreatment on cardiomyocytes with hypoxia\/reoxygenation injury and the possible mechanism","volume":"11","author":"Qin","year":"2008","journal-title":"Chin. J. Trauma."},{"key":"10.1016\/j.biopha.2024.116764_bib190","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.lfs.2005.09.053","article-title":"Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion","volume":"78","author":"Liu","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib191","first-page":"71","article-title":"Erythropoietin Attenuates Pulmonary Vascular Remodeling in Experimental Pulmonary Arterial Hypertension through Interplay between Endothelial Progenitor Cells and Heme Oxygenase","volume":"3","author":"van Loon","year":"2015","journal-title":"Front Pedia"},{"issue":"1","key":"10.1016\/j.biopha.2024.116764_bib192","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41598-021-81422-1","article-title":"Remote liver ischemic preconditioning attenuates myocardial ischemia\/reperfusion injury in streptozotocin-induced diabetic rats","volume":"11","author":"Liu","year":"2021","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.biopha.2024.116764_bib193","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.3390\/ijms23179634","article-title":"The Association of Erythropoietin and Age-Related Macular Degeneration in Hemodialysis Patients: A Nationwide Population-Based Cohort Study","volume":"23","author":"Huang","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib194","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.surg.2009.03.022","article-title":"Carbamylated erythropoietin protects the myocardium from acute ischemia\/reperfusion injury through a PI3K\/Akt-dependent mechanism","volume":"146","author":"Xu","year":"2009","journal-title":"Surgery"},{"issue":"14","key":"10.1016\/j.biopha.2024.116764_bib195","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.3390\/ijms241411507","article-title":"Carbamoylated Erythropoietin-Induced Cerebral Blood Perfusion and Vascular Gene Regulation","volume":"24","author":"Sadanandan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib196","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1196\/annals.1415.000","article-title":"Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium","volume":"1112","author":"Smart","year":"2007","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2024.116764_bib197","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fphar.2016.00115","article-title":"Systemic dosing of thymosin beta 4 before and after ischemia does not attenuate global myocardial ischemia-reperfusion injury in pigs","volume":"7","author":"Stark","year":"2016","journal-title":"Front Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:01Z","timestamp":1781650741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224006486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":197,"alternative-id":["S0753332224006486"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116764","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress on the protective effect of hormones and hormone drugs in myocardial ischemia-reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116764"}}